This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Q. Articles by Taketo, M. M. Search for Related Content PubMed PubMed Citation Articles by Li, Q. Articles by Taketo, M. M.

The Threshold Level of Adenomatous Polyposis Coli Protein for Mouse Intestinal Tumorigenesis

¹ Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto, Japan and ² Department of Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Requests for reprints: Makoto M. Taketo, Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-konoé-cho, Sakyo-ku, Kyoto, Japan. Phone: 81-75-753-4391; Fax: 81-75-753-4402; E-mail: taketo{at}mfour.med.kyoto-u.ac.jp.

The adenomatous polyposis coli (APC) gene, whose mutations are responsible for familial adenomatous polyposis, is a major negative controller of the Wnt/ß-catenin pathway. To investigate the dose-dependent effects of APC protein in suppressing intestinal tumorigenesis, we constructed mutant mice carrying hypomorphic Apc alleles Apc^neoR and Apc^neoF whose expression levels were reduced to 20% and 10% of the wild type, respectively. Although both hypomorphic heterozygotes developed intestinal polyps, tumor multiplicities were much lower than that in Apc⁷¹⁶ mice, heterozygotes of an Apc null allele. Like in Apc⁷¹⁶ mice, loss of the wild-type Apc allele was confirmed for all polyps examined in the Apc^neoR and Apc^neoF mice. In the embryonic stem cells homozygous for these hypomorphic Apc alleles, the level of the APC protein was inversely correlated with both the ß-catenin accumulation and ß-catenin/T-cell factor transcriptional activity. These results suggest that the reduced APC protein level increases intestinal polyp multiplicity through quantitative stimulation of the ß-catenin/T-cell factor transcription. We further estimated the threshold of APC protein level that forms one polyp per mouse as 15% of the wild type. These results also suggest therapeutic implications concerning Wnt signaling inhibitors.

This article has been cited by other articles:

				U. Dougherty, D. Cerasi, I. Taylor, M. Kocherginsky, U. Tekin, S. Badal, L. Aluri, A. Sehdev, S. Cerda, R. Mustafi, et al. Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor-{alpha} and PTGS2 Clin. Cancer Res., November 15, 2009; 15(22): 6780 - 6789. [Abstract] [Full Text] [PDF]

				K. Yang, N. Kurihara, K. Fan, H. Newmark, B. Rigas, L. Bancroft, G. Corner, E. Livote, M. Lesser, W. Edelmann, et al. Dietary Induction of Colonic Tumors in a Mouse Model of Sporadic Colon Cancer Cancer Res., October 1, 2008; 68(19): 7803 - 7810. [Abstract] [Full Text] [PDF]

				J. Schneikert and J. Behrens The canonical Wnt signalling pathway and its APC partner in colon cancer development Gut, March 1, 2007; 56(3): 417 - 425. [Full Text] [PDF]

				P. Bjorklund, G. Akerstrom, and G. Westin Accumulation of Nonphosphorylated {beta}-Catenin and c-myc in Primary and Uremic Secondary Hyperparathyroid Tumors J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 338 - 344. [Abstract] [Full Text] [PDF]